Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3648 publications

Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.

Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.

Journal: Cureus
Published: September 01, 2025

Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction.

Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction.

Journal: JAMA
Published: August 31, 2025

Prevalence and Predictors of Post-coital Hypoglycemia in Diabetes Mellitus.

Prevalence and Predictors of Post-coital Hypoglycemia in Diabetes Mellitus.

Journal: Cureus
Published: August 30, 2025

A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats.

A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats.

Journal: International journal of toxicology
Published: August 30, 2025

Drug Repurposing for Targeting Cancer Stem-like Cells in Glioblastoma.

Drug Repurposing for Targeting Cancer Stem-like Cells in Glioblastoma.

Journal: Cancers
Published: August 20, 2025

Drug Repurposing Patent Applications January-March 2025.

Drug Repurposing Patent Applications January-March 2025.

Journal: Assay and drug development technologies
Published: August 12, 2025

Effectiveness of Sitagliptin and Empagliflozin Combination Therapy in a Patient With Charcot-Marie-Tooth Disease and Comorbid Diabetes Mellitus: A Case Report.

Effectiveness of Sitagliptin and Empagliflozin Combination Therapy in a Patient With Charcot-Marie-Tooth Disease and Comorbid Diabetes Mellitus: A Case Report.

Journal: Cureus
Published: August 12, 2025

Association Between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use and All-Cause Mortality in Patients With Pulmonary Arterial Hypertension.

Association Between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use and All-Cause Mortality in Patients With Pulmonary Arterial Hypertension.

Journal: Cureus
Published: August 05, 2025

Fournier's Gangrene Associated With Ertugliflozin.

Fournier's Gangrene Associated With Ertugliflozin.

Journal: Journal of pharmacy practice
Published: July 28, 2025

Liquid chromatography-tandem mass spectrometry method for quantification of ertugliflozin in human plasma: Application to disposition kinetics.

Liquid chromatography-tandem mass spectrometry method for quantification of ertugliflozin in human plasma: Application to disposition kinetics.

Journal: European journal of mass spectrometry (Chichester, England)
Published: July 15, 2025

Modulation of NF-кB/NLRP3 signaling by sitagliptin attenuates cholestatic hepatic fibrosis.

Modulation of NF-кB/NLRP3 signaling by sitagliptin attenuates cholestatic hepatic fibrosis.

Journal: Toxicology and applied pharmacology
Published: July 03, 2025

The Impact of Semaglutide on Metabolic Syndrome: A Case Report.

The Impact of Semaglutide on Metabolic Syndrome: A Case Report.

Journal: Cureus
Published: July 03, 2025
Showing 1-12 of 3,648

Last Updated: 10/31/2025